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Objective: Because of the small numbers of thoracic outlet syndrome (TOS) patients treated with bilateral ﬁrst rib
resection and scalenectomy (FRRS), this patient subset has not been well studied. We examined a large cohort of TOS
patients who underwent bilateral FRRS to evaluate patient characteristics and outcomes.
Methods: Patients treated with bilateral FRRS at Johns Hopkins Medical Institutions from 2003 to 2012 were identiﬁed
by review of a prospectively maintained database. Statistical analysis compared patients with unilateral and bilateral FRRS
and bilateral patients with different TOS indications.
Results: Fifty-three patients underwent bilateral FRRS with a mean follow-up of 11.4 months. Average time between
operations was 17.0 months (range, 5.1-59.8 months). Compared with 408 unilateral FRRS patients, bilateral patients
were younger (30 vs 35 years; P[ .012), with no signiﬁcant difference in gender. Among patients with dual-sided FRRS,
25 (47%) had bilateral neurogenic symptoms, 2 (4%) had bilateral arterial symptoms, and 26 (49%) had venous symptoms
with the ﬁrst side due to intermittent compression in 5 (second side: four, intermittent compression; one, neurogenic) and
effort thrombosis in 21 (second side: 9, effort thrombosis; 8, intermittent compression; 4, neurogenic). Ten patients had
prophylactic FRRS to prevent contralateral venous or arterial thrombosis, and eight had cervical ribs. Compared with
neurogenic patients, venous patients were younger (25 vs 35 years; P < .001), with a trend toward more competitive
athletes (seven venous vs two neurogenic). Symptomatic restenosis requiring dilation occurred after four FRRS for
venous symptoms at a mean of 32.4 months, and rethrombosis occurred after four FRRS at a mean of 4 weeks (one
treated with warfarin, three with tissue plasminogen activator), all on the primary side. Overall, 88% of FRRS for
symptomatic TOS led to resolved symptoms at last follow-up.
Conclusions: Bilateral FRRS is an effective method for treatment of TOS. Venous bilateral patients more often are younger,
are competitive athletes, and require close postoperative monitoring for recurrent stenosis and thrombosis. (J Vasc Surg
2014;60:185-90.)Thoracic outlet syndrome (TOS) is a condition caused
by compression of the neurovascular structures passing
through the thoracic inlet. TOS can be categorized into
three distinct subtypes according to the type of compres-
sion: neurogenic (roots of the brachial plexus, 95% of
cases), venous (subclavian vein, 4%-5% of cases), and arte-
rial (subclavian artery, 1% of cases). Anatomic predisposi-
tions (cervical ribs, abnormal ﬁrst ribs) and extrinsic
factors like trauma or chronic repetitive movements may
result in TOS.1 Conservative management for the condi-
tion often consists of physical therapy, lifestyle modiﬁca-
tions such as rest and ergonomic changes, and selective
pharmacologic therapy. About 30% to 40% of TOS patients
do not achieve adequate symptom relief with conservative
therapy. In these cases, the “gold standard” treatment isthe Division of Vascular Surgery and Endovascular Therapy, Johns
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(FRRS). The procedure is usually performed unilaterally
by a transaxillary or supraclavicular approach and consists
of division of the anterior scalene muscle and removal of
the ﬁrst rib.2 FRRS has been shown to improve mental
and physical quality of life scores for appropriately selected
TOS patients in both short- and long-term follow-up
studies.3,4
Some patients experience bilateral TOS symptoms
before or after a primary FRRS and may choose to have a
second operation on the contralateral side. Because a mi-
nority of TOS patients undergo bilateral FRRS, little is
known about this patient population. Small sample size
has limited prior examination of bilateral FRRS in the liter-
ature to a minor subset within larger studies.4-8 Unique
characteristics and outcomes of this patient population
have not been investigated, and these are necessary to
determine whether it is ever acceptable for patients to un-
dergo bilateral FRRS. The objective of this study was to
evaluate the demographic and clinical characteristics, indi-
cations for surgery, and outcomes of TOS patients under-
going bilateral FRRS.METHODS
Study participants. Patients who underwent FRRS
for TOS by a single surgeon at Johns Hopkins Hospital
from 2003 to 2012 were identiﬁed by retrospective review185
Fig 1. Presentation of bilateral ﬁrst rib resection and scalenectomy (FRRS) patients. ET, Effort thrombosis;
IC, intermittent compression.
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Vascular Surgery and Endovascular Therapy has Institu-
tional Review Board approval to prospectively maintain
the database, which consists of demographic and clinical
characteristics including age, gender, TOS type (neuro-
genic, venous, arterial), TOS side, and surgery date. All pa-
tients had failed to respond to prior conservative treatment
involving at least 8 weeks of physical therapy. Patients un-
dergoing bilateral FRRS were identiﬁed by the presence of
two surgery dates listed within the database.
Diagnosis of TOS was based on detailed history and
physical examination. Relief from preoperative anterior
scalene block with bupivacaine or lidocaine conﬁrmed a
diagnosis of neurogenic TOS in select cases, in which relief
is deﬁned as symptom resolution of more than 50%. Preop-
erative upper extremity duplex scanning or venography and
angiography were employed to assess vessel patency in
cases of venous and arterial TOS, respectively. Signiﬁcant
compression was deﬁned as complete cessation of ﬂow on
abduction. Patients with venous TOS were further catego-
rized as having an effort thrombosis (Paget-Schroetter syn-
drome) if there was evidence of thrombosis on duplex
scanning or venography or having intermittent compres-
sion (McCleery syndrome) if compression of the subclavian
vein on abduction occurred in the absence of a venous
thrombosis. Follow-up testing for patients with venous or
arterial TOS included duplex scans at postoperative visits
intended to assess patency and to direct further therapy.
Data collection. Demographic and clinical variables
were extracted from the internal database. Additional vari-
ables collected from review of patient charts for bilateral
FRRS patients included presence of cervical ribs, participa-
tion in competitive athletics, prophylactic treatment, com-
plications, incidence and date of restenosis or rethrombosis,
and date of last clinic visit. Prophylactic treatment was
deﬁned as FRRS in the setting of contralateral venous or
arterial thrombosis to prevent the development of a
thrombus on the second side. The second side had evi-
dence of compression by physical examination or duplex
scan of the subclavian artery or vein. Symptoms after
FRRS were categorized as resolved, unresolved, or recur-
rent on the basis of clinical assessment at the last postoper-
ative clinic visit. Resolved symptoms referred to relief ofTOS-related impairment in accordance with best clinical
practice and were considered successful outcomes. Unre-
solved symptoms were those that persisted in the post-
operative period, and these cases were considered failures.
Symptoms were classiﬁed as recurrent if they reappeared
after initial resolution. In all cases, unresolved or recurrent
symptoms were equivalent in nature to those reported
preoperatively.
Statistical methods. Wilcoxon rank sum and c2 tests
were used to evaluate whether there were differences in
age and gender, respectively, between patients who under-
went unilateral and bilateral FRRS. Wilcoxon rank sum,
Kruskal-Wallis, and Fisher exact tests were used to deter-
mine whether there were differences in patient factors and
outcomes among bilateral FRRS patients with different
TOS types (neurogenic, venous, arterial). Statistical sig-
niﬁcance was deﬁned as P < .05. Analysis was performed
with Stata/SE software, version 10.1 (Stata Corp, College
Station, Tex).
RESULTS
A total of 461 patients underwent FRRS from 2003 to
2012. Fifty-three patients had bilateral FRRS (106 cases),
and 408 patients were treated with unilateral FRRS. Bilat-
eral FRRS patients were younger than unilateral FRRS
patients (P ¼ .012), with a mean age of 30 years (range,
16-58 years) compared with 35 years (range, 11-79 years)
for unilateral patients. The bilateral group had 16 men
(30%) and 37 women (70%) compared with 130 men
(32%) and 278 women (68%) in the unilateral group, a dif-
ference that was not statistically signiﬁcant.
Among the 53 patients who underwent bilateral FRRS,
the mean time between operations was 17.0 months
(range, 5.1-59.8 months), and mean follow-up time was
11.4 months. Twenty-ﬁve patients (47%) had bilateral
neurogenic symptoms, 2 (4%) had bilateral arterial symp-
toms, and 26 (49%) had venous symptoms. Among the
venous patients, the ﬁrst side was due to intermittent
compression in ﬁve (second side: four, intermittent
compression; one, neurogenic) and effort thrombosis in
21 (second side: 9, effort thrombosis; 8, intermittent
compression; 4, neurogenic). A schematic of TOS presen-
tation for bilateral FRRS is illustrated in Fig 1.
Table I. Comparison of patient and clinical
characteristics, by patienta
Neurogenic TOS
(n ¼ 25),
No. (%)
Venous TOS
(n ¼ 26),
No. (%)
Arterial TOS
(n ¼ 2),
No. (%)
Mean age, yearsb 35 25 32
Gender
Male 5 (20) 11 (42) 0 (0)
Female 20 (80) 15 (58) 2 (100)
Cervical ribs 4 (16) 2 (8) 2 (100)
Competitive athletes 2 (8) 7 (27) 0 (0)
Prophylactic 0 (0) 8 (31) 2 (100)
TOS, Thoracic outlet syndrome.
aPatients are categorized on the basis of presentation on the ﬁrst side.
bAge at ﬁrst surgery.
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FRRS patients are shown in Table I. Mean age at ﬁrst oper-
ation was 35 years for neurogenic TOS patients, 25 years
for venous TOS patients, and 32 years for arterial TOS pa-
tients; TOS type (neurogenic, venous, arterial) refers to the
presentation on the ﬁrst side. Furthermore, patients with
venous TOS were signiﬁcantly younger than those with
neurogenic TOS (P < .001). There was no signiﬁcant dif-
ference in gender among patients with neurogenic TOS
(20 women, ﬁve men), venous TOS (15 women, 11
men), and arterial TOS (two women, zero men). Bilateral
cervical ribs were present in 4 (16%) neurogenic TOS pa-
tients, 2 (8%) venous TOS patients, and 2 (100%) arterial
TOS patients. Five patients were found to carry one or
more hypercoagulable conditions: three had a MTHFR
mutation, two were factor V Leiden, two had anticardioli-
pin antibodies, one had lupus anticoagulant, and one had
dysﬁbrinogenemia. There was a nonsigniﬁcant trend to-
ward more competitive athletes in the venous TOS group
(n ¼ 7; 27%) compared with the neurogenic (n ¼ 2; 8%)
and arterial (n ¼ 0) groups.
Of the 25 patients who underwent dual-sided FRRS
for treatment of neurogenic TOS, 15 received lidocaine
blocks (14 of these provided symptom relief) in the ante-
rior scalene muscle on the ﬁrst side before primary FRRS,
and ﬁve of these also received Botox blocks (only one
improved symptoms). Twenty patients experienced com-
plete symptom resolution on the initial side after FRRS,
whereas three patients had residual symptoms, and two
experienced a recurrence of symptoms after initial improve-
ment that ultimately led to resolution of symptoms with
physical therapy by the end of the follow-up period. The
mean time between operations for bilateral neurogenic pa-
tients was 16.9 months (range, 7.4-49.4 months).
On the second side, three patients had lidocaine blocks
only (all provided symptom relief), two had Botox blocks
only (one improved symptoms), and one had both lido-
caine and Botox blocks (only the lidocaine block provided
symptom relief). Of the 50 FRRS cases for bilateral neuro-
genic TOS, there were 11 pneumothoraces identiﬁed at the
time of FRRS and managed with a 12F intraoperative chesttube placement, removed the next morning. There were
three cases of wound healing problems, and one patient
experienced persistent scapular winging despite normal
ﬁndings on electromyography. One patient developed a
hematoma postoperatively that resolved without further
surgical intervention. One patient had signiﬁcant postoper-
ative bleeding following the ﬁrst FRRS that required reop-
eration with a thoracotomy to ligate an avulsed branch of
the subclavian artery.
Five patients were treated with FRRS for intermittent
venous compression on the ﬁrst side. Of these, four had
intermittent venous compression on the second side and
the remaining patient displayed neurogenic TOS on the
second side. All of these patients had symptoms (pain,
heaviness, discoloration, paresthesias, numbness) on
both sides, and two of ﬁve were competitive athletes.
One of these patients displayed complete venous ablation
on abduction during duplex scanning of the second side.
Dual-sided intermittent compression patients had a
mean time between FRRS procedures of 18.9 months
(range, 5.0-34.7 months). There were 11.6 months be-
tween FRRS procedures for the patient with neurogenic
indications on the second side, and this patient did not
have a lidocaine or Botox block. One patient with inter-
mittent compression on both sides had an intraoperative
pneumothorax and another experienced wound healing
problems.
Twenty-one patients were treated for venous TOS
from effort thrombosis on the ﬁrst side. Nine of these pa-
tients also developed effort thrombosis on the second
side, although only one showed signs of bilateral thrombo-
ses before the initial surgery. Three of the eight patients
who subsequently thrombosed the second side had duplex
scans before the initial operation, showing complete abla-
tion of the contralateral subclavian vein on abduction.
Two of these patients tested positive for hypercoagulable
states; both had a MTHFR mutation, one of which was
also factor V Leiden, and had dysﬁbrinogenemia. The
mean interoperative time was 22.4 months (range, 6.7-
59.8 months). Of the 18 FRRS procedures performed on
these patients with bilateral effort thromboses, there were
ﬁve pneumothoraces, one wound infection, and one hema-
toma. There were no nerve injuries.
Eight patients with effort thrombosis on the ﬁrst side
experienced asymptomatic intermittent compression on
the second side. Seven of these demonstrated complete
ablation of the subclavian vein during abduction on duplex
scanning; the eighth showed 90% venous compression.
Three of the patients who had intermittent compression
on the second side after effort thrombosis on the ﬁrst
side were competitive athletes. The second FRRS proce-
dure in this group was done to prevent possible thrombosis
in the future. Mean time between FRRS procedures was
12.5 months (range, 9.6-17.0 months). Three intraopera-
tive pneumothoraces occurred during the 16 FRRS proce-
dures performed on this group of patients. There were no
wound problems, bleeding, or nerve injuries.
Fig 2. Recurrent symptoms after bilateral ﬁrst rib resection and
scalenectomy (FRRS) for venous thoracic outlet syndrome (TOS).
tPA, Tissue plasminogen activator.
Table II. Comparison of outcomes, by sidea
Neurogenic TOS
(n ¼ 55),
No. (%)
Venous TOS
(n ¼ 39),
No. (%)
Arterial TOS
(n ¼ 2),
No. (%)
Resolved 44 (80) 29 (74) 2 (100)
Recurrent 2 (4) 9 (23) 0 (0)
Unresolved 8 (15) 0 (0) 0 (0)
Unknown 1 (2) 1 (3) 0 (0)
TOS, Thoracic outlet syndrome.
Percentages may not add to 100% because of rounding.
aEach side is assigned an independent outcome. Prophylactic cases are
excluded.
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bosis on the ﬁrst side developed signs and symptoms of
neurogenic TOS on the second side. Two of the patients
also had hypercoagulable disorders; one was factor V Leiden
and had a MTHFR mutation, and the other tested positive
for anticardiolipin antibodies. Themean time between oper-
ations was 16.6 months (range, 9.9-26.8 months). Of eight
FRRS procedures in this group, two had pneumothoraces,
and there were no wound problems or bleeding issues.
Two patients were treated with bilateral FRRS for arte-
rial TOS, presenting as thrombosis. These patients both
had bilateral cervical ribs with asymptomatic compression
and underwent prophylactic FRRS to prevent contralateral
thrombosis. Duplex scans showed almost 50% arterial
compression on abduction of the second side for both pa-
tients. Mean interoperative time was 8.1 months (range,
2.5-13.6 months). Of the four FRRS cases for arterial
TOS, two resulted in pneumothoraces that were success-
fully managed with intraoperative chest tube placement.
There were no other complications.
A total of 11 (10%) FRRS led to recurrent symptoms
during the follow-up period. Two cases were after FRRS
for neurogenic TOS, and both patients ultimately experi-
enced resolution of symptoms with physical therapy by
the end of the follow-up period. As is shown in Fig 2,
symptomatic restenosis requiring dilation occurred after
four FRRS for venous TOS at a mean of 32.4 months.
All of these cases were managed with dilation with balloon
angioplasty. Symptomatic rethrombosis occurred after four
FRRS for venous TOS at a mean of 4 weeks; one case was
treated with anticoagulation (warfarin), and the other three
were managed with tissue plasminogen activator. Six of
these eight patients (75%) had successful outcomes after
intervention. Of the two patients who did not achieve
eventual resolution of symptoms, one had an unknown
ﬁnal outcome due to insufﬁcient follow-up, and the other
experienced chronic intermittent swelling. An additional
venous TOS patient experienced transient pain and
swelling on one surgical side that was treated as superﬁcial
phlebitis with aspirin and compresses.
Of 96 FRRS for symptomatic TOS, 75 (78%) led to
resolved symptoms, with an overall success rate of 88%
when the nine cases of recurrent symptoms that eventually
achieved symptom resolution were included. The 10 pro-
phylactic FRRS (eight with venous compression and two
with arterial compression) were also considered successful,
given the absence of complications or other signiﬁcant
postoperative issues at last follow-up. There was no signif-
icant difference in successful outcome by TOS type. In
addition to the two cases of persistent recurrent symptoms,
cases without a successful outcome included eight cases
with unresolved symptoms and two with unknown
outcome due to insufﬁcient follow-up. Outcomes after
bilateral FRRS are shown in Table II.
DISCUSSION
Although FRRS is considered the optimal treatment of
TOS patients who fail to respond to conservativemanagement, bilateral FRRS has not yet been explicitly
supported by the literature. A lack of long-term data neces-
sitate further investigation into the outcomes of dual-sided
FRRS for patients experiencing bilateral symptoms. In
contrast to previous studies that examined small groups
of bilateral patients within larger analyses, our study inves-
tigated the characteristics and outcomes of 53 patients who
underwent bilateral FRRS. Our study is unique in its inves-
tigation of bilateral FRRS for treatment of TOS that is both
neurogenic and vascular in origin and also in its involve-
ment of a sizable cohort of patients treated with bilateral
FRRS. This study is the ﬁrst to examine bilateral FRRS as
treatment and to speciﬁcally compare the experiences of
patients undergoing unilateral and dual-sided procedures.
In our analysis, 88% of symptomatic FRRS ultimately
led to resolved symptoms, which compares favorably with
recorded outcomes of unilateral FRRS for patients with
varied TOS indications.5,9-11 Our ﬁndings indicate that
bilateral FRRS is a safe and effective method for treatment
of TOS and that an interoperative time of at least 1 year
may facilitate favorable outcomes.
In contrast to previous studies that showed no differ-
ence in demographic and clinical characteristics between
groups,5 our comparison of patients who underwent uni-
lateral and bilateral FRRS established that bilateral patients
were younger. Age younger than 40 years is a signiﬁcant
JOURNAL OF VASCULAR SURGERY
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pression of the thoracic outlet.12 Our ﬁnding supports
the notion that surgeons are more inclined to select
younger patients for bilateral FRRS, thereby predicting
better outcomes. Surgical decision-making plays a major
role in determining which of the subset of patients who
present with bilateral symptoms of TOS go on to have a
second operation. It is also possible that younger patients
engage in higher intensity repetitive motion activities like
athletics, shown to cause the majority of contralateral
TOS symptoms, and are therefore more likely to experi-
ence symptoms bilaterally.5,13
Our study also sought to investigate the conditions un-
der which dual-sided FRRS led to positive outcomes. Pre-
viously, our review of 35 adolescents who underwent
FRRS found that two patients who presented with effort
thrombosis on the ﬁrst side had prophylactic contralateral
rib resections for venous compression seen by duplex scan-
ning. These two procedures led to favorable outcomes,
and patients were able to continue with high-intensity
physical activity with no return of symptoms.14 In the cur-
rent study, 43 patients received treatment for bilateral
symptomatic TOS, whereas 10 patients underwent pro-
phylactic FRRS to prevent contralateral venous or arterial
thrombosis after the primary FRRS for venous or arterial
thrombosis. Of note, in our bilateral effort thrombosis
group, three patients had evidence of asymptomatic
contralateral compression on the initial duplex scan that
led to thrombosis at an average of 22 months later. In re-
view of the literature, only one study by Azakie et al15 eval-
uated contralateral asymptomatic compression. They
found that 9 of 33 patients who underwent FRRS experi-
enced high-grade asymptomatic stenosis in the contralat-
eral subclavian vein. One of these patients underwent
prophylactic supraclavicular FRRS.
Some authors advocate that FRRS should be used only
as a last resort to avoid surgical complications or worsening
prognosis after surgery.16 Our ﬁndings suggest that bilat-
eral FRRS can effectively treat symptomatic TOS and is
also a consideration for patients who have had a venous
or arterial thrombosis on one side and are at risk for devel-
opment of a contralateral thrombosis.
Cervical ribs were another common feature among our
bilateral FRRS patient population. The prevalence of cervi-
cal ribs in the general population is approximately 0.2% to
1.0%, with half of those cases occurring bilaterally. In
contrast, cervical ribs are found in a higher proportion of
TOS patients, approximately 5% to 10%.17-19 In our study
of bilateral FRRS, 15% of patients presented with cervical
ribs, a higher proportion than most reported in the litera-
ture. However, Davies et al20 reported a study of 58 pa-
tients with TOS, 22 of whom displayed cervical ribs. It is
worthwhile to continue to investigate the role of cervical
ribs in TOS, particularly in patients with bilateral symp-
toms. The majority of patients with cervical ribs present
with venous or arterial TOS, and it is important to
completely resect the ﬁrst rib and cervical rib in most pa-
tients to achieve full symptom resolution.21Our study also compared characteristics and surgical
outcomes of patients with different indications for bilateral
FRRS. Compared with patients with neurogenic TOS,
primary side venous patients averaged about 10 years
younger. Venous patients were also more often competitive
athletes than were neurogenic bilateral FRRS patients.
The association between venous TOS and high-intensity
athleticism has been well described in the literature.1,14,22
This trend may help explain the differences in age found
among venous and neurogenic TOS patients.
Outcomes of bilateral FRRS were largely positive in
this patient population. Symptomatic restenosis or
rethrombosis occurred after a total of eight FRRS, all on
the primary operative side. Although venous TOS patients
required additional interventions in the setting of restenosis
or rethrombosis, there was no signiﬁcant difference in suc-
cess rate among patients with different TOS indications.
Overall, most patients had successful outcomes after
FRRS on both sides, suggesting that FRRS is safe and
effective for treatment of TOS. We recommend allowing
at least 1 year of recovery time between operations, as
this helped facilitate favorable outcomes in the study pop-
ulation by allowing sufﬁcient rehabilitation of the ﬁrst sur-
gical side before the second operation. In addition, venous
bilateral patients must be monitored closely postoperatively
for recurrent stenosis and thrombosis. We obtain postoper-
ative venous duplex scans at 6 months and 1 year. If symp-
toms of swelling occur, a duplex scan can be ordered to
examine abduction and adduction velocities, and diag-
nostic and possibly therapeutic venography can be per-
formed with balloon angioplasty.
One major limitation to our study is the retrospective
study design. Although a prospective, randomized
controlled trial would be preferable for investigating the
safety and efﬁcacy of bilateral FRRS, it was not possible
to randomize patients into treatment groups. Rather, surgi-
cal decision-making followed from diagnostic and clinical
criteria, and patient demographics and certain clinical char-
acteristics could not be controlled. An additional limitation
is the subjective nature of characterizing factors such as
pain, range of motion, discoloration, swelling, and physical
impairment. Last, our analysis deals only with the patient
population at one institution. Any deﬁnitive recommenda-
tions about bilateral FRRS would beneﬁt from multicenter
reports with a larger sample size than we present here.
Furthermore, given the greater proportion of venous
TOS patients in our study compared with prevalence rates
in the general TOS population (49% vs 4% to 5%), future
studies should investigate whether patients with venous
symptoms are signiﬁcantly more likely to have bilateral
rather than unilateral TOS compared with patients with
neurogenic and arterial symptoms.
CONCLUSIONS
We have compared patient characteristics and out-
comes of unilateral and bilateral FRRS and examined the as-
sociation between different TOS indications and outcomes.
Our analysis contains the largest sample of bilateral TOS
JOURNAL OF VASCULAR SURGERY
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practice. The data and outcomes reported in our study will
help guide treatment decisions for patients who present
with dual-sided TOS symptoms or who are candidates for
prophylactic FRRS after surgery on the contralateral side
for a venous or arterial thrombosis. FRRS is well known
as an effective treatment strategy when it is performed
unilaterally, and our ﬁndings reveal that FRRS can also be
safe and effective when it is performed bilaterally.
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